UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047267
Receipt number R000053511
Scientific Title Verification test of body fat reduction effect by ingesting test food
Date of disclosure of the study information 2022/06/19
Last modified on 2024/03/22 16:05:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification test of body fat reduction effect by ingesting test food

Acronym

Body fat reduction test by food intake

Scientific Title

Verification test of body fat reduction effect by ingesting test food

Scientific Title:Acronym

Body fat reduction test by food intake

Region

Japan


Condition

Condition

healthy participants

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confirm the effect of reducing body fat by ingesting food.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Body fat 8 weeks,12 weeks after the start of food intake

Key secondary outcomes

8, 12 weeks after the start of feeding
Belly fat
Body weight
BMI
Waist circumference


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Ingest foods containing 100 mg of plant-derived extract for 12 weeks

Interventions/Control_2

Ingest foods containing 300 mg of plant-derived extract for 12 weeks

Interventions/Control_3

Inoculate placebo food for 12 weeks

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Persons with a BMI of 23 kg /m2 or more and less than 30 kg / m2
(2) Obese people with a lot of body fat
(3) Persons who voluntarily consent to participate in the examination by writing

Key exclusion criteria

(1) Those who are currently judged to have dyslipidemia or hypertension and are undergoing some kind of treatment.
(2) Ingesting foods and health foods containing the ingredients involved in this test food (plant extract)person
(3) Health foods and dietary supplements related to cholesterol, blood pressure, blood lipids, and blood sugar levelsThose who use it regularly
(4) Glucose metabolism, lipid metabolism, liver disease, renal disease, cardiovascular disease, digestive disease, respiratory disease, blood Persons with serious diseases such as humoral diseases, autoimmune diseases, endocrine diseases, and metabolic diseases.Or a person who has a medical history
(5) Persons with a history of drug allergies or serious food allergies
(6) Persons who have had abnormal laboratory test values and were judged to have problems participating in the study
(7) Persons with illnesses who are currently undergoing hospital visits, treatment, use of medications / external medicines, and follow-up
(8) Those who were judged to be inappropriate as subjects based on the results of the subject background questionnaire.
(9) Those who participated in other clinical studies at the start of this study
(10) Those who are pregnant or plan to breastfeed during the study period
(11) Persons who are judged by the investigator (or the person in charge of conducting the examination) to be inappropriate for participating in the examination

Target sample size

75


Research contact person

Name of lead principal investigator

1st name Sumio
Middle name
Last name Kondo

Organization

Medicial Corporation Kenshokai

Division name

Fukushima Healthcare Center

Zip code

553-0004

Address

Tamagawa 2-12-16, Fukushima-ku, Osaka-shi, Osaka, 553-0004, Japan

TEL

06-6441-6848

Email

drc_shokuhin@drc-web.co.jp


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name Furusyo

Organization

DRC Co., Ltd

Division name

Food Human Testing Division

Zip code

530-0044

Address

5F, 9th Tabuchi Building, Higashitenma 2-10-31, Kita-Ku, Osaka city

TEL

06-6882-1130

Homepage URL


Email

drc_shokuhin@drc-web.co.jp


Sponsor or person

Institute

Medicial Corporation Kenshokai, Fukushima Healthcare Center

Institute

Department

Personal name



Funding Source

Organization

Iwase Cosfa Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Brain Care Clinic Ethics Review Committee

Address

Samon-Cho13, Isobe Build. 2F, Shinjyuku-ku, Tokyo

Tel

03-3351-3386

Email

drc_shokuhin@drc-web.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 02 Month 03 Day

Date of IRB

2022 Year 02 Month 10 Day

Anticipated trial start date

2022 Year 03 Month 07 Day

Last follow-up date

2022 Year 06 Month 19 Day

Date of closure to data entry

2022 Year 12 Month 31 Day

Date trial data considered complete

2022 Year 12 Month 31 Day

Date analysis concluded

2022 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 03 Month 23 Day

Last modified on

2024 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000053511


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name